ARID1A mutations are detected with high frequency in tumor samples of entities including endometrioid and clear-cell ovarian cancer (>40%), gastric cancer, bladder cancer, hepatocellular cancer, colorectal cancer and melanoma (11.5%) [12]. Here, ARID1A is linked to melanoma.